There is no single national NHS waiting-list figure for weight-loss injections — waits vary widely by area, by which service you are referred to, and by how tightly NHS eligibility is being prioritised. In practice, many people face a long wait (often many months, and in some areas considerably longer) because NHS prescribing is being rolled out in stages and reserved for those who meet strict clinical criteria first.
This article explains why there is no one answer, what drives the delay, who the NHS prioritises, and the practical alternatives if you cannot or do not want to wait.
Why there is no single NHS waiting-time figure
Weight-loss injections on the NHS are not a simple "join one list" situation. Access depends on several moving parts, which is why quoted waits range from months to years depending on where you live.
- Phased rollout. NHS England is introducing some weight-management medicines gradually, starting with people at the highest clinical need. This staged approach means demand far outstrips the number of people being started at any one time.
- Local commissioning. Integrated Care Boards and local services decide how pathways run in their area, so the route and the wait differ from one postcode to the next.
- Service capacity. Many medicines are tied to specialist weight-management services, which have limited appointment capacity and their own referral backlogs.
- Eligibility tiering. Criteria are often stricter than the general licensing criteria, so many people who would qualify privately do not yet meet the NHS threshold.
Because of all this, any "X weeks" figure you see online is usually a local snapshot, not a national guarantee. Your GP or local weight-management service is the only reliable source for the wait in your specific area.
Who does the NHS prioritise first?
NHS pathways generally prioritise people with the highest BMI and the greatest weight-related health risk — for example a very high BMI combined with conditions such as type 2 diabetes, high blood pressure or obstructive sleep apnoea. People closer to the minimum thresholds typically wait longer or may not currently qualify.
You usually need to go through your GP or a specialist service to be assessed, and starting treatment is tied to structured support such as diet, activity and behavioural help — not the medicine alone.
What this means in practice
If you are considering the NHS route, it is worth:
- Speaking to your GP about whether you meet local criteria and how the pathway works where you live.
- Asking specifically about the current wait for your nearest weight-management service.
- Understanding that being eligible on paper does not mean an immediate start — capacity and tiering both apply.
For many people, the realistic timeline is long and uncertain, which is why they look at a regulated private route in the meantime.
The private alternative: faster access, same medicines
A regulated UK online pharmacy can offer the same MHRA-licensed medicines without a waiting list, provided treatment is clinically appropriate for you. The medicine is identical to what the NHS prescribes — the difference is the route and that you pay privately.
At The Weight Clinic, treatment is prescribed by a GPhC-registered independent prescriber and dispensed by our own GPhC-registered pharmacy (North Harrow Pharmacy, registration number 1034996), which you can verify on the General Pharmaceutical Council register. We supply only genuine, MHRA-licensed medicines — never unlicensed or grey-market products.
The process starts with a free online consultation: a prescriber reviews your answers to check treatment is safe and suitable, a short video consultation is arranged where clinically needed, and if appropriate the medicine is dispensed and sent by tracked delivery. A prescription is only issued if it is clinically appropriate — it is never guaranteed.
Which injectable treatments are available privately?
Several licensed options exist, and the right one depends on your health, preferences and prescriber assessment. You can read more on each product page.
| Treatment | How it works | From (per month) |
|---|---|---|
| Mounjaro (tirzepatide) | Weekly injection activating two gut-hormone receptors, GLP-1 and GIP | £160 |
| Wegovy injection (semaglutide) | Once-weekly GLP-1 injection that curbs appetite and slows stomach emptying | £115 |
In the SURMOUNT-1 trial, participants on the Mounjaro 15mg dose lost on average 22.5% of body weight over 72 weeks, alongside lifestyle support. In the STEP UP clinical trial, adults on the Wegovy 7.2mg dose lost on average 20.7% of their body weight over 72 weeks, alongside lifestyle support. Individual results vary; not everyone reaches this.
Prefer a tablet to an injection?
If needles are a barrier, there are now licensed oral options too. The Wegovy Tablet is the same active medicine as the Wegovy injection, taken as a once-daily tablet first thing on an empty stomach with a small sip of plain water, then waiting at least 30 minutes before eating, drinking or taking other medicines.
There is also Foundayo (orforglipron), the first small-molecule (non-peptide) GLP-1 pill and the first designed to be taken at any time of day, with or without food or water. It received a UK marketing authorisation on 10 August 2026 and is in stock across all strengths. You can compare these on our treatments overview or the weight-loss injections page.
In the OASIS 4 trial, adults on oral semaglutide 25mg lost on average 16.6% of their body weight over 64 weeks, alongside lifestyle support. In the Phase 3 ATTAIN-1 trial, participants on the 36mg dose lost on average 12.4% of their body weight over 72 weeks, alongside lifestyle counselling. Individual results vary; not everyone reaches this. These are separate trials, not head-to-head comparisons.
Am I eligible?
Whether NHS or private, broadly similar clinical criteria apply. You generally need to be aged 18 or over with a BMI of 30 or more, or a BMI of 27–30 with a weight-related condition such as type 2 diabetes, high blood pressure or sleep apnoea.
These treatments are not suitable if you are pregnant, planning pregnancy or breastfeeding, have type 1 diabetes, a personal or family history of medullary thyroid cancer or MEN2, a history of pancreatitis, severe gastrointestinal disease, an active eating disorder, severe liver or kidney impairment, or a known allergy to the active ingredient.
Side effects to be aware of
These medicines share a similar side-effect profile. Common effects (more than 1 in 10 people) include nausea, diarrhoea, constipation, vomiting, reduced appetite and fatigue. Serious but rare effects include severe allergic reaction, acute pancreatitis, severe hypoglycaemia, severe gastrointestinal disease and worsening diabetic retinopathy.
If you experience a side effect, you can report it through the MHRA Yellow Card scheme at https://yellowcard.mhra.gov.uk/.
NHS or private — which is right for you?
The NHS route is free but access is phased, tiered by clinical priority, and often involves a significant wait that varies by area. A regulated private route avoids the waiting list and gives you choice of licensed treatments, but you pay for it — prices start from £115 per month depending on the medicine and dose.
There is no single "best" answer; it depends on your health, your eligibility and how long you are able to wait. If you want to understand your options, a prescriber can review your situation through our free consultation, and you can always contact us with questions first.
This article is for information only and is not a substitute for personalised medical advice. Weight-loss medicines are prescription-only, are not suitable for everyone, and are prescribed only after a clinical consultation with a GPhC-registered prescriber. Individual results vary. Always speak to a UK-registered pharmacist or doctor before starting or changing any prescription medication.
